Stock Analysis on Net
Stock Analysis on Net

Medtronic PLC (NYSE:MDT)

$24.99

Common-Size Income Statement

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check

Medtronic PLC, common-size consolidated income statement

Microsoft Excel
12 months ended: Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Net sales
Cost of products sold, excluding amortization of intangible assets
Gross profit
Research and development expense
Selling, general, and administrative expense
Amortization of intangible assets
Restructuring charges, net
Certain litigation charges, net
Other operating income (expense), net
Operating profit
Other non-operating income, net
Interest expense, net
Income before income taxes
Income tax (provision) benefit
Net income
Net income attributable to noncontrolling interests
Net income attributable to Medtronic

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).


The common-size income statement analysis for the period from April 2021 to April 2026 reveals a profile of stable gross margins and a general trend toward improved operating efficiency, despite volatility in net income margins.

Gross Profitability Trends
Gross profit margins remained relatively consistent over the analyzed period, fluctuating within a narrow range between 65.02% and 67.98%. A peak was observed in April 2022 at 67.98%, followed by a slight normalization to approximately 65% in the subsequent years. This indicates a stable relationship between net sales and the cost of products sold, suggesting consistent pricing power and cost management of direct production expenses.
Operating Expense Management
Research and development (R&D) expenses showed a gradual downward trend as a percentage of net sales, declining from a peak of 8.67% in 2022 to 7.90% by 2026. Selling, general, and administrative (SG&A) expenses remained stable, generally hovering between 32% and 34%, with a slight contraction observed in the final two years of the period. Additionally, amortization of intangible assets as a percentage of sales decreased steadily from 5.92% in 2021 to 4.87% in 2026, contributing to a relative reduction in total operating overhead.
Operating Profit Performance
Operating profit margins experienced an initial increase from 14.89% in 2021 to a peak of 18.15% in 2022. While there was a temporary decline to 15.89% in 2024, the margin recovered and stabilized at approximately 17.7% through 2026. This suggests that improvements in operating margins were primarily driven by the reduction in amortization and R&D intensities rather than significant shifts in gross margins.
Net Income and Non-Operating Factors
Net income attributable to the parent company exhibited more volatility than operating profit. A significant peak occurred in April 2022 at 15.90%, followed by a sharp decline to 11.36% in 2024. This volatility is partly attributable to fluctuations in the income tax provision, which peaked at 5.06% of net sales in 2023 before moderating. By 2026, the net income margin reached a stabilized level of 13.20%. Interest expenses remained relatively controlled, fluctuating between 1.75% and 3.07% of net sales, indicating a stable debt-servicing burden relative to revenue.